Stay updated on Durvalumab & Olaparib in Endometrial Cancer Clinical Trial

Sign up to get notified when there's something new on the Durvalumab & Olaparib in Endometrial Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Durvalumab & Olaparib in Endometrial Cancer Clinical Trial page

  1. Check
    yesterday
    No Change Detected
  2. Check
    8 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.15.0 to version 2.15.2.
    Difference
    0.1%
    Check dated 2025-04-30T13:58:56.000Z thumbnail image
  3. Check
    15 days ago
    No Change Detected
  4. Check
    23 days ago
    Change Detected
    Summary
    The webpage has undergone significant updates, including the removal of detailed descriptions of a Phase III study involving durvalumab and the addition of new identifiers and collaborators related to endometrial neoplasms and drug treatments.
    Difference
    15%
    Check dated 2025-04-16T02:55:14.000Z thumbnail image
  5. Check
    30 days ago
    Change Detected
    Summary
    The web page has updated its version from v2.14.3 to v2.14.4, and a date has been added for February 11, 2025. However, the deletion of the date March 25, 2025, indicates a potential change in scheduling or availability.
    Difference
    0.3%
    Check dated 2025-04-09T00:45:39.000Z thumbnail image
  6. Check
    37 days ago
    Change Detected
    Summary
    The page has been updated to reflect a new last update date of March 25, 2025, and a revision change to version 2.14.3, replacing the previous date of February 11, 2025, and version 2.14.2.
    Difference
    0.2%
    Check dated 2025-04-01T19:08:20.000Z thumbnail image
  7. Check
    66 days ago
    Change Detected
    Summary
    The page has removed a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products.
    Difference
    1.0%
    Check dated 2025-03-03T22:23:36.000Z thumbnail image
  8. Check
    80 days ago
    Change Detected
    Summary
    The webpage has updated its date references, moving from November 2024 to February 2025, indicating a shift in the timeline of content. Additionally, there is a change in numerical values associated with the content, suggesting a possible update in data or statistics.
    Difference
    0.6%
    Check dated 2025-02-17T15:37:22.000Z thumbnail image

Stay in the know with updates to Durvalumab & Olaparib in Endometrial Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Durvalumab & Olaparib in Endometrial Cancer Clinical Trial page.